These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5369189)

  • 1. Treatment of muscular dystrophy with laevadosin.
    Das Gupta A
    J Indian Med Assoc; 1969 Oct; 53(8):390-2. PubMed ID: 5369189
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of muscular dystrophy.
    Bastron JA
    Mod Treat; 1966 Mar; 3(2):298-303. PubMed ID: 5324817
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of muscular dystrophy with "Laevadosin".
    Lip P; Flanagan J; Murray P
    Med J Aust; 1969 Jun; 1(26):1386. PubMed ID: 5797171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical aspects and therapy of muscular dystrophies].
    Beckmann R
    Internist (Berl); 1972 Mar; 13(3):108-17. PubMed ID: 4553893
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 7. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of the therapeutic effect of bemitil in neuromuscular diseases].
    Lobzin VS; Saĭkova LA; Chukhlovina ML; Pustozerov VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):22-4. PubMed ID: 1664607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H; Stenzel K; Migea S; Bordeianu L
    Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of muscular dystrophy with "laevadosin".
    Hudgson P; Walton JN
    Med J Aust; 1969 Oct; 2(15):776. PubMed ID: 5351054
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB; Rea F; Capasso DA
    Boll Soc Ital Biol Sper; 1965 Aug; 41(16):901-4. PubMed ID: 5880029
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological therapies for muscular dystrophies.
    Abdel-Hamid H; Clemens PR
    Curr Opin Neurol; 2012 Oct; 25(5):604-8. PubMed ID: 22941265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of bemitil in patients with progressive muscular dystrophies].
    Lobzin VS; Saĭkova LA; Chukhlovina ML; Pustozerov VG
    Lik Sprava; 1992 Apr; (4):85-7. PubMed ID: 1441389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.
    Bushby K; Muntoni F; Bourke JP
    Neuromuscul Disord; 2003 Feb; 13(2):166-72. PubMed ID: 12565916
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL; Caprarulo CC; Luchetta MR; Nenkies L; Miani J; De Zubizarreta CS
    Prensa Med Argent; 1966 May; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution to the muscular dystrophy treatment.
    Tomaszkiewicz JA; Kossatz-Bielecka DE
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):92. PubMed ID: 4870251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.